|
|
News for Healthier Living
AAN Issues Position Statement on Possible Therapies for Neurological Conditions
The American Academy of Neurology (AAN) has issued a position statement on therapies for neurological conditions that have limited evidence or no approved use by the Food and Drug Administration (FDA). The statement is published June 25, 2025, in Neurology(r), the medical journal of the American Academy of Neurology. The statement includes guiding principles for discussions with patients and policymakers about these therapies. Although the statement includes illustrative examples, it does not provide clinical recommendations regarding the use of specific therapies.
June 25, 2025
June 27 2025June 26 2025June 25 2025June 24 2025June 23 2025June 22 2025June 21 2025June 20 2025June 19 2025June 18 2025 - Consensus Statement on Universal Chemosensory Testing Calls for Better Standardization, Infrastructure, and Education in the Field
- Babies' Babbling Offers Insight Into Cognitive Ability at Age 30 and Beyond
- Expanding Essential Wound Care for People Who Use Drugs
- Gene Hunt Leads to Potential Colorectal Cancer Treatment, Stanley J. Glaser Award
- A Year After Transplant, Cured Diabetes Patient Graduates, Celebrates
- A New Timeline for Parkinson's Disease
- Researchers Find Climate Change Threatens Global Food Supply
- Scientists Find Cellular Brain Changes Tied to PTSD
- More Smokers Quit After Big Hike in California Tobacco Tax
- CSUF's Innovation Hub to Propel Future Engineers and Computer Scientists
- How Wildfires Might Increase Risk Of Flu, COVID-19
- Braces Top Best Therapies For Knee Arthritis
- Food Insecurity, Neighborhood, Lack of Social Support, Linked to Worse Stroke Recovery
- What Is a Brain Age Gap, and How May It Affect Thinking and Memory Skills?
- Illuminating Gaps in Perinatal Palliative Care Evidence Amidst Abortion Restrictions
- CDC Vaccine Expert Resigns After RFK Jr. Cuts Advisers
- Kraft Heinz to Remove Artificial Dyes From Products by 2027
- Tracking Microbial Rhythms Reveals New Target for Treating Metabolic Diseases
- Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
- Gene-Editing System Targets Multiple Organs Simultaneously
- Targeting Pol 1 Could Rewire Cancer Cells and Suppress Tumor Growth
- Researchers Identify Key B-Cell Lymphoma Traits Linked with Greatest Benefit From CD19 CAR T Cell Therapy
- Mayo Clinic Q & A: Why a Fluttering Heart Could Lead to Stroke
- Protein Assisting with Injury in Acute Pancreatitis Can Delay Tissue Recovery in Chronic Pancreatitis
- AI Boosts Skin Cancer Diagnoses, Study Says
- Night Shift Associated With Asthma Risk In Women
- Infertility Tied To Heart Problems In Women
- Talk Therapy Eases Depression, Anxiety In Stroke Survivors
- Operation Bangui: The Untold Story of AIDS Research in Africa
- The Medical Minute: Top 7 Tips for Safe Outdoor Exercise
- Neuroscientist Searches for Ways to Reduce Seizures in Children
- Ear Wax as a Possible Screening Medium for Parkinson's Disease
- Genetic testing for children with autism and intellectual disabilities remains rare in Medicaid, despite national guidelines
- Gut Microbiome Composition and Food Insecurity Linked to Risk of Cognitive Impairment in Adults
- Study Compares Indoor Transmission-Risk Metrics for Infectious Diseases
June 17 2025June 16 2025 - Grateful Dental Patient Fashions a Sculpture of Gratitude
- Researchers Examine the Impact of Mycoestrogen Exposure on Birth Outcomes
- Improving Cancer Outcomes with Better Lynch Syndrome Testing: A Cost-Benefit Study
- This Summer, Don't Let Dehydration Ruin Your Workout
- Mapping the Genetic Landscape of Yellow Catfish for Sustainable Aquaculture
- Light-activated Metal Catalyst Selectively Converts CO2 to Industrial Chemical
- Medicaid Cuts in The "One Big Beautiful Bill Act" Could Undermine the Coverage, Financial Well-Being, Medical Care, and Health of Low-Income Americans, and Lead to More Than 16,500 Medically
- Semaglutide More Effective at Lowering Risk for Stroke and Other Cardiovascular Outcomes Compared to Empagliflozin
- Phase 3 Trial Suggests Fecal Transplant Is as Effective as Antibiotics for Treating C. Diff Infection
- Screening for Anal Cancer Most Cost-Effective When Initiated at Age 35
- Texas Invests $50M in Psychedelic Drug Research to Treat Addiction
- New COVID Variant, NB.1.8.1, May Now Make Up 1 in 3 U.S. Cases
- Bugaboo Recalls 18,000+ Giraffe High Chairs Due to Fall Risk
- Father's Mental Health Plays Key Role in Child Development, Research Shows
- 7 Questions About Hernias
- Rising T1DE Alliance Adds Lurie Children's to Further Disseminate New Data-Driven Care Model for Type 1 Diabetes
- Rheumatoid Arthritis On The Rise Worldwide, AI-Powered Study Estimates
- COVID Vaccine Protects Against Kidney Damage During Infection
- New Tool Improves the Detection of Hidden Genetic Mutations
- Innovative Once-Weekly Capsule Helps Quell Schizophrenia Symptoms
- Improving the Well-Being of Health Care Workers
- ADHD Stimulants Can Be Safely Prescribed Via Telehealth, Study Argues
- Children With MS Age Faster, Study Says
- Turnaround Month In U.S. OD Death Crisis Pinpointed By Researchers
- In Stereo: Neurons Shift Gears Between Thoughts Using Brain Rhythms
- Hold the Cream and Sugar: Black Coffee Linked to Lower Risk of Death
- Cancer Before 40: Mayo Clinic Expert Shares 3 Topics That Younger Patients Often Want to Discuss
- National Poll: Many Parents Struggle Letting Teens Have Independence on Family Vacations
June 15 2025June 14 2025June 13 2025
|
|
|
|
|